Skip to main content

Table 3 Comparison of treatment modalities

From: Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China

Treatment modalities

No.(%)

Age (year)

MELD Score

Survival time (months)

Drugs (At first diagnosis)

20/131(15%)

53.35 ± 11.91

10.14(0.47–24.7)

19(14–23)

Thoracic intubation (At first diagnosis)

111/131(75%)

57.32 ± 11.83

10.22(0.00-30.50)

22(17–26)

TIPS (At post-treatment)

1/131(0.7%)

45

16

32

LT (At post-treatment)

3/131(2.2%)

52

18

-

  1. Data are expressed as mean (± standard deviation), median (quartile 25, quartile 75) or number (proportion). Survival time are expressed as the estimated median time (95% CI)
  2. TIPS Transjugular intrahepatic portosystemic shunt, LT Liver transplantation, MELD model for end-stage liver disease, CI confidence interval